Oppenheimer upgraded Emerson (NYSE: EMR) from Perform to Outperform with a price target of $77.00.

Analyst Christopher Glynn comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE